Eversept Partners, LP
- SEC CIK
- 0001697013
- Latest filing
- Aug 14, 2026
MRVI holding history
Maravai Lifesciences Holdings, Inc. in every 13F filed by Eversept Partners, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MRVI overviewAll 13F holders of MRVIFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −718,582−100.0% | Sold out | Holders |
| Q4 2025 | 718,582 | $2.34M | 0.1% | +427,909+147.2% | Added | Holders |
| Q3 2025 | 290,673 | $834.2K | 0.1% | −350,000−54.6% | Reduced | Holders |
| Q2 2025 | 640,673 | $1.54M | 0.2% | −301,781−32.0% | Reduced | Holders |
| Q1 2025 | 942,454 | $2.08M | 0.2% | +942,454 | New | Holders |
| Q4 2024 | 0 | $0 | 0.0% | −336,966−100.0% | Sold out | Holders |
| Q3 2024 | 336,966 | $2.80M | 0.2% | +336,966 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −452,323−100.0% | Sold out | Holders |
| Q3 2023 | 452,323 | $4.52M | 0.5% | +452,323 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −160,000−100.0% | Sold out | Holders |
| Q3 2022 | 160,000 | $4.08M | 0.5% | −265,364−62.4% | Reduced | Holders |
| Q2 2022 | 425,364 | $12.1M | 1.2% | +425,364 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −87,795−100.0% | Sold out | Holders |
| Q4 2021 | 87,795 | $3.68M | 0.3% | −240,015−73.2% | Reduced | Holders |
| Q3 2021 | 327,810 | $16.1M | 1.3% | +252,810+337.1% | Added | Holders |
| Q2 2021 | 75,000 | $3.13M | 0.3% | +75,000 | New | Holders |